Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-volume low-concentration versus standard ropivacaine infusion for continuous adductor canal block after total knee arthroplasty
TCTR20261007009Phase 4Not yet recruiting
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine in knee osteoarthritis (OA), sponsored by None. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on TCTR20261007009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261007009.